Showing 1 - 20 results of 24 for search 'Jacques Delaunay', query time: 0.06s Refine Results
  1. 1
    Optically Pumped Hybrid Plasmonic-Photonic Waveguide Modulator Using the VO2 Metal-Insulator Phase Transition

    Optically Pumped Hybrid Plasmonic-Photonic Waveguide Modulator Using the VO2 Metal-Insulator Phase Transition by J. Kenji Clark, Ya-Lun Ho, Hiroaki Matsui, Jean-Jacques Delaunay

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Modulating Ni/Ce Ratio in Ni<i><sub>y</sub></i>Ce<sub>100−</sub><i><sub>y</sub></i>O<i><sub>x</sub></i> Electrocatalysts for Enhanced Water Oxidation

    Modulating Ni/Ce Ratio in Ni<i><sub>y</sub></i>Ce<sub>100−</sub><i><sub>y</sub></i>O<i><sub>x</sub></i> Electrocatalysts for Enhanced Water Oxidation by Jun Yu, Qi Cao, Chen Qiu, Lei Chen, Jean-Jacques Delaunay

    Published 2021-02-01
    Get full text
    Article
  3. 3
    Unusual effects of vacuum annealing on large-area Ag3PO4 microcrystalline film photoanode boosting cocatalyst- and scavenger-free water splitting

    Unusual effects of vacuum annealing on large-area Ag3PO4 microcrystalline film photoanode boosting cocatalyst- and scavenger-free water splitting by Qi Cao, Jun Yu, Yue Cao, Jean-Jacques Delaunay, Renchao Che

    Published 2021-09-01
    Get full text
    Article
  4. 4
    Thresholdless behavior and linearity of the optically induced metallization of NbO_{2}

    Thresholdless behavior and linearity of the optically induced metallization of NbO_{2} by J. Kenji Clark, Ya-Lun Ho, Hiroaki Matsui, Hitoshi Tabata, Jean-Jacques Delaunay

    Published 2019-12-01
    Get full text
    Article
  5. 5
    Combination of an Axicon Fiber Tip and a Camera Device into a Sensitive Refractive Index Sensor

    Combination of an Axicon Fiber Tip and a Camera Device into a Sensitive Refractive Index Sensor by Yi-Hsin Tai, Po-Cheng Tsai, Ya-Lun Ho, Jean-Jacques Delaunay, Pei-Kuen Wei

    Published 2019-11-01
    Get full text
    Article
  6. 6
    Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia

    Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemia by Jacques Delaunay, Grzegorz Mazur, Mark Minden, Agnieszka Wierzbowska, Mark M. Jones, Erhan Berrak, Hagop M. Kantarjian

    Published 2014-01-01
    Get full text
    Article
  7. 7
    Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia

    Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia by Thomas Prebet, Sarah Bertoli, Jacques Delaunay, Arnaud Pigneux, Eric Delabesse, Marie Joelle Mozziconacci, Audrey Bidet, Christian Recher, Norbert Vey

    Published 2014-10-01
    Get full text
    Article
  8. 8
    Continuous Blood Pressure Monitoring in Daily Life

    Continuous Blood Pressure Monitoring in Daily Life by Guillaume LOPEZ, Masaki SHUZO, Hiroyuki USHIDA, Keita HIDAKA, Shintaro YANAGIMOTO, Yasushi IMAI, Akio KOSAKA, Jean-Jacques DELAUNAY, Ichiro YAMADA

    Published 2010-02-01
    Get full text
    Article
  9. 9
    High-Q lasing via all-dielectric Bloch-surface-wave platform

    High-Q lasing via all-dielectric Bloch-surface-wave platform by Yang-Chun Lee, Ya-Lun Ho, Bo-Wei Lin, Mu-Hsin Chen, Di Xing, Hirofumi Daiguji, Jean-Jacques Delaunay

    Published 2023-10-01
    Get full text
    Article
  10. 10
    Wearable Eating Habit Sensing System Using Internal Body Sound

    Wearable Eating Habit Sensing System Using Internal Body Sound by Masaki SHUZO, Shintaro KOMORI, Tomoko TAKASHIMA, Guillaume LOPEZ, Seiji TATSUTA, Shintaro YANAGIMOTO, Shin&apos;ichi WARISAWA, Jean-Jacques DELAUNAY, Ichiro YAMADA

    Published 2010-02-01
    Get full text
    Article
  11. 11
    A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM)

    A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe... by Lionel Ades, Agnès Guerci-Bresler, Pascale Cony-Makhoul, Laurence Legros, Marie Sebert, Thorsten Braun, Jacques Delaunay, Kristell Desseaux, Sylvie Chevret, Pierre Fenaux

    Published 2019-04-01
    Get full text
    Article
  12. 12
    The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features

    The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features by Marion Eveillard, Jacques Delaunay, Steven Richebourg, Laurence Lodé, Richard Garand, Soraya Wuillème, François Duhoux, Hélène Antoine-Poirel, Catherine Godon, Marie C. Béné

    Published 2015-03-01
    Get full text
    Article
  13. 13
    Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies

    Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies by Claire Oudin, Patrice Chevallier, Sabine Furst, Thierry Guillaume, Jean El Cheikh, Jacques Delaunay, Luca Castagna, Catherine Faucher, Angela Granata, Raynier Devillier, Christian Chabannon, Benjamin Esterni, Norbert Vey, Mohamad Mohty, Didier Blaise

    Published 2014-11-01
    Get full text
    Article
  14. 14
    Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study

    Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study by Patrice Chevallier, Francoise Huguet, Emmanuel Raffoux, Anne Etienne, Thibaut Leguay, Francoise Isnard, Nelly Robillard, Thierry Guillaume, Jacques Delaunay, Aude Charbonnier, Arnaud Pigneux, Pierre Peterlin, Marie C. Bené, William A. Wegener, David M. Goldenberg, Hervé Dombret

    Published 2015-04-01
    Get full text
    Article
  15. 15
    Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial

    Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial by Patrice Chevallier, Myriam Labopin, Gérard Socié, Reza Tabrizi, Sabine Furst, Bruno Lioure, Thierry Guillaume, Jacques Delaunay, Régis Peffault de La Tour, Stéphane Vigouroux, Jean El-Cheikh, Didier Blaise, Mauricette Michallet, Karin Bilger, Noel Milpied, Philippe Moreau, Mohamad Mohty

    Published 2014-09-01
    Get full text
    Article
  16. 16
    NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

    NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML by Anne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, Florence Orlanducci, Samia Harbi, Aude Le Roy, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Jean-François Hamel, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet-Lefebvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Didier Blaise, Daniel Olive

    Published 2017-12-01
    Get full text
    Article
  17. 17
    Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

    Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Franc... by Lionel Adès, Fabien Le Bras, Marie Sebert, Charikleia Kelaidi, Thierry Lamy, François Dreyfus, Virginie Eclache, Jacques Delaunay, Didier Bouscary, Sorin Visanica, Pascal Turlure, Agnès Guerci Bresler, Marie-Paule Cabrol, Anne Banos, Michel Blanc, Norbert Vey, Alain Delmer, Eric Wattel, Sylvie Chevret, Pierre Fenaux

    Published 2012-02-01
    Get full text
    Article
  18. 18
    Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide

    Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide by Laurence Lodé, Audrey Ménard, Laurent Flet, Steven Richebourg, Marion Loirat, Marion Eveillard, Yannick Le Bris, Catherine Godon, Olivier Theisen, Anne-Laure Gagez, Guillaume Cartron, Thérèse Commes-Maerten, Bruno Villemagne, Odile Luycx, Pascal Godmer, Catherine Pellat-Deceunynck, Thierry Soussi, Marie C. Béné, Jacques Delaunay, Pierre Peterlin

    Published 2018-04-01
    Get full text
    Article
  19. 19
    Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

    Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies by Charikleia Kelaidi, Aspasia Stamatoullas, Odile Beyne-Rauzy, Emmanuel Raffoux, Bruno Quesnel, Agnes Guerci, François Dreyfus, Sabine Brechignac, Christian Berthou, Thomas Prebet, Yosr Hicheri, Maya Hacini, Jacques Delaunay, Marie-Pierre Gourin, Jean-Marie Camo, Hacene Zerazhi, Anne-Laure Taksin, Laurence Legros, Bachra Choufi, Pierre Fenaux

    Published 2010-06-01
    Get full text
    Article
  20. 20
    Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group

    Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter... by Sarah Bertoli, Pierre Bories, Marie C. Béné, Sylvie Daliphard, Bruno Lioure, Arnaud Pigneux, Norbert Vey, Jacques Delaunay, Vincent Leymarie, Isabelle Luquet, Odile Blanchet, Pascale Cornillet-Lefebvre, Mathilde Hunault, Didier Bouscary, Nathalie Fegueux, Philippe Guardiola, François Dreyfus, Jean Luc Harousseau, Jean Yves Cahn, Norbert Ifrah, Christian Récher

    Published 2014-01-01
    Get full text
    Article

Search Tools: